 | | | | |
| |  | |  | | |
| |
 |
| PRIME NEWS | |
|
 |
|
|
Japan's Astellas Pharma has launched a hostile bid to acquire OSI Pharmaceuticals, a Nasdaq listed developer of molecular targeted therapies for oncology, diabetes and obesity
|
|
|
|
|
|
|
|
|
A new report released recently said medicine sales in Japan will decline from $85.8bn in 2008 to $84.6bn in 2018. However, in local currency terms, the market will actually expand by a compound annual growth rate (CAGR) of 1.11%
|
|
|
|
|
|
|
| | | 
BioSpectrum Japan is uniquely positioned as a specialized information platform for Japanese medical technology articles. It brings to you comprehensive coverage and useful Japan medical news in the areas of pharmaceuticals industry in Japan, Japanese medical technology, Japan medical devices and Biotech.
| | | | |  | |  | | |
|
|
 |
|
 |
|
|
|
 |
NEWS |
 |
|
|
|
Shionogi to market QuatRx Pharmas' Ospemifene
|
|
| Japanese pharma company Shionogi and QuatRx Pharmaceuticals, a privately-held pharmaceutical company, today announced that they have entered into a worldwide license agreement to develop and market ospemifene, a selective estrogen receptor modulator |
|
|
|
|
|
|
|
|
 |
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PEOPLE |
|
|
|
|
GSK Japan gets new President
|
|
| GlaxoSmithKline has appointed Mr Philippe Fauchet as the President of GSK Japan. Mr Fauchet joins GSK from Sanofi Aventis where he was Senior Vice President, Business Development |
|
|
|
|
|
Nu Skin Japan appoints Dr Makoto Kuro-O to its SAB
|
|
| Nu Skin Japan also announced Dr Makoto Kuro-O, associate professor of pathology at the University of Texas Southwestern Medical Center, as a new member of its Anti-Aging Scientific Advisory Board (SAB) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PRODUCTS |
|
|
|
|
Abbott's XIENCE V gets MHLW approval
|
|
| Abbott announced that the Japanese Ministry of Health, Labor and Welfare (MHLW) has approved its XIENCE V Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease. The company plans to launch XIENCE V in Japan soon |
|
|
|
|
|
Nu Skin launches ageLOC product in Japan
|
|
| Nu Skin Enterprises introduced the new ageLOC Future Serum to more than 10,000 sales representatives at its launch event in Japan. Japanese distributors were eager to be in the first market to fully launch one of the company's new ageLOC skin care |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|  | |  | | | | |  | |  |
|
|
|
| | | | | | | | |
